1. Home
  2. AROW vs AURA Comparison

AROW vs AURA Comparison

Compare AROW & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

HOLD

Current Price

$38.30

Market Cap

727.1M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.70

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROW
AURA
Founded
1851
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
727.1M
797.5M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AROW
AURA
Price
$38.30
$7.70
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$28.00
$20.00
AVG Volume (30 Days)
72.6K
772.3K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
3.33%
N/A
EPS Growth
49.72
N/A
EPS
1.48
N/A
Revenue
N/A
N/A
Revenue This Year
$33.36
N/A
Revenue Next Year
$18.26
N/A
P/E Ratio
$25.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.91
$4.73
52 Week High
$42.70
$9.54

Technical Indicators

Market Signals
Indicator
AROW
AURA
Relative Strength Index (RSI) 39.23 53.38
Support Level $37.23 $6.49
Resistance Level $40.29 $7.83
Average True Range (ATR) 0.80 0.46
MACD -0.09 -0.02
Stochastic Oscillator 46.45 47.84

Price Performance

Historical Comparison
AROW
AURA

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: